| P50 | author | Emmanouil Papadakis | Q91893633 |
| P2093 | author name string | P Kotsi | |
| | A Pouliakis | |
| | E Grouzi | |
| | A Christoforidou | |
| | A Foifa | |
| | G Αnagnostou | |
| | Α Aktypi | |
| P2860 | cites work | The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome | Q37124833 |
| | The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology | Q37412076 |
| | Thromboembolic disorders in obstetrics | Q37960708 |
| | Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine? | Q38193203 |
| | LMWH to prevent placenta-mediated pregnancy complications: an update | Q38268419 |
| | Aspirin and heparin in pregnancy | Q38544097 |
| | Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. | Q38695989 |
| | Risks of Venous Thromboembolism After Cesarean Sections: A Meta-Analysis. | Q38854692 |
| | The prevention and treatment of venous thromboembolism in pregnancy | Q39251751 |
| | Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial | Q42617261 |
| | Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles | Q43712296 |
| | Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study | Q45061360 |
| | Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study | Q45237814 |
| | Increased venous thrombosis incidence in pregnancies after in vitro fertilization | Q45838812 |
| | Tinzaparin use in pregnancy: an international, retrospective study of the safety and efficacy profile | Q46326461 |
| | Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality | Q46341891 |
| | Efficacy of low molecular weight heparin in patients undergoing in vitro fertilization or intracytoplasmic sperm injection | Q47350607 |
| | Low molecular weight heparin modulates maternal immune response in pregnant women and mice with thrombophilia. | Q47419189 |
| | Low-molecular -weight heparin in pregnancies after ART -a retrospective study-. | Q47577695 |
| | An investigation of Caesarean sections in three Greek hospitals: the impact of financial incentives and convenience | Q48486933 |
| | Administration of low-molecular-weight heparin in patients with two or more unsuccessful IVF/ICSI cycles: a multicenter cohort study | Q49714633 |
| | Prevention, management and extent of adverse pregnancy outcomes in women with hereditary antithrombin deficiency. | Q51208615 |
| | Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception. | Q51452267 |
| | Prevalence of thrombosis-related DNA polymorphisms in a healthy Greek population. | Q55056860 |
| | Recurrent miscarriage | Q56503650 |
| | How I treat heterozygous hereditary antithrombin deficiency in pregnancy | Q60312160 |
| | Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy | Q73145258 |
| | Haemostatic changes in pregnancy | Q73429692 |
| | Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study | Q80947501 |
| | Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study | Q81588010 |
| | Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients | Q81670366 |
| | Endogenous thrombin potential, prothrombin fragment 1+2 and D-dimers during pregnancy | Q82300158 |
| | Venous thromboembolism in pregnancy: diagnosis, management and prevention | Q83460748 |
| | Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms | Q84798076 |
| | Practice bulletin no. 123: thromboembolism in pregnancy | Q84807873 |
| | Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia | Q24194917 |
| | Heparin for assisted reproduction | Q24200403 |
| | Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction | Q24201073 |
| | VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q24632982 |
| | Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications | Q27027687 |
| | Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis | Q27692668 |
| | Pregnancy failure and heritable thrombophilia | Q28222297 |
| | International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 |
| | Anticoagulants to prevent recurrent placenta-mediated pregnancy complications: Is it time to put the needles away? | Q30235424 |
| | Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. | Q33365697 |
| | Risk of a thrombotic event after the 6-week postpartum period | Q33671499 |
| | Clinical guidelines for testing for heritable thrombophilia | Q34096556 |
| | Antithrombotic therapy for pregnancy loss | Q34350806 |
| | Effect of heparin on the outcome of IVF treatment: a systematic review and meta-analysis | Q34446265 |
| | The physiologic and therapeutic role of heparin in implantation and placentation | Q35007371 |
| | Venous thromboembolism and antithrombotic therapy in pregnancy | Q35187737 |
| | Caesarean deliveries in the Mother-Child (Rhea) cohort in Crete, Greece: almost as frequent as vaginal births and even more common in first-time mothers. | Q35678280 |
| | Pregnancy-related venous thrombosis: comparison between spontaneous and ART conception in an Italian cohort | Q36178815 |
| | Guidance for the treatment and prevention of obstetric-associated venous thromboembolism | Q36471056 |
| | Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study | Q36536244 |
| | Tissue factor-dependent thrombin generation across pregnancy | Q36865746 |
| P921 | main subject | Greece | Q41 |
| P304 | page(s) | 23 | |
| P577 | publication date | 2019-12-04 | |
| P1433 | published in | Thrombosis journal | Q27719507 |
| P1476 | title | Low molecular weight heparins use in pregnancy: a practice survey from Greece and a review of the literature | |
| P478 | volume | 17 | |